Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity
- PMID: 18075673
- DOI: 10.1039/b712728f
Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity
Abstract
The in vivo formation of fibrillar proteinaceous deposits called amyloid is associated with more than 40 serious human diseases, collectively referred to as protein deposition diseases. In many cases the amyloid deposits are extracellular and are found associated with newly identified abundant extracellular chaperones (ECs). Evidence is presented suggesting an important regulatory role for ECs in amyloid formation and disposal in the body. A model is presented which proposes that, under normal conditions, ECs stabilize extracellular misfolded proteins by binding to them, and then guide them to specific cell receptors for uptake and subsequent degradation. Thus ECs and their receptors may be critical parts of a quality control system to protect the body against dangerously hydrophobic proteins/peptides. However, it also appears possible that in the presence of a high molar excess of misfolded protein, such as might occur during disease, the limited amounts of ECs available may actually exacerbate pathology. Further advances in understanding of the mechanisms that control extracellular protein folding are likely to identify new strategies for effective disease therapies.
Similar articles
-
Chapter 6: The chaperone action of Clusterin and its putative role in quality control of extracellular protein folding.Adv Cancer Res. 2009;104:89-114. doi: 10.1016/S0065-230X(09)04006-8. Adv Cancer Res. 2009. PMID: 19878774 Review.
-
Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?Biomark Med. 2010 Dec;4(6):831-4. doi: 10.2217/bmm.10.108. Biomark Med. 2010. PMID: 21133702 No abstract available.
-
The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin.Biochemistry. 2005 Aug 16;44(32):10914-25. doi: 10.1021/bi050764x. Biochemistry. 2005. PMID: 16086594
-
Roles of extracellular chaperones in amyloidosis.J Mol Biol. 2012 Aug 24;421(4-5):499-516. doi: 10.1016/j.jmb.2012.01.004. Epub 2012 Jan 10. J Mol Biol. 2012. PMID: 22248589 Review.
-
Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins.J Biochem. 2009 Dec;146(6):751-6. doi: 10.1093/jb/mvp119. Epub 2009 Jul 30. J Biochem. 2009. PMID: 19643812 Review.
Cited by
-
Characterization of Plasma SDS-Protein Aggregation Profile of Patients with Heart Failure with Preserved Ejection Fraction.J Cardiovasc Transl Res. 2023 Jun;16(3):698-714. doi: 10.1007/s12265-022-10334-w. Epub 2022 Oct 21. J Cardiovasc Transl Res. 2023. PMID: 36271180
-
Modulation of Alzheimer's Disease Aβ40 Fibril Polymorphism by the Small Heat Shock Protein αB-Crystallin.J Am Chem Soc. 2024 Jul 17;146(28):19077-19087. doi: 10.1021/jacs.4c03504. Epub 2024 Jul 7. J Am Chem Soc. 2024. PMID: 38973199 Free PMC article.
-
α2-macroglobulin in Alzheimer's disease: new roles for an old chaperone.Biomark Med. 2018 Apr;12(4):311-314. doi: 10.2217/bmm-2018-0027. Epub 2018 Mar 14. Biomark Med. 2018. PMID: 29537301 Free PMC article. No abstract available.
-
Cooperative stabilization of transthyretin by clusterin and diflunisal.Biochemistry. 2015 Jan 20;54(2):268-78. doi: 10.1021/bi5011249. Epub 2014 Dec 24. Biochemistry. 2015. PMID: 25478940 Free PMC article.
-
A Proteomic Atlas of Cardiac Amyloid Plaques.JACC CardioOncol. 2020 Nov;2(4):632-643. doi: 10.1016/j.jaccao.2020.08.013. Epub 2020 Nov 17. JACC CardioOncol. 2020. PMID: 33511353 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
